RLAY
Relay Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$19.18-3.67%
Price as of Jul 20, 2026
RLAY valuation
Relay Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 740.85x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.72x
- Price / sales
- 344.16x
- Price / cash flow
- -17.22x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 286.98x
- EV / EBITDA
- -11.21x
- EV / EBIT
- -10.34x
- Market cap
- $3.7B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.